An experimental blood test could help detect early pancreatic cancer and precancerous changes, guiding decisions about further testing. People at high risk of pancreatic cancer are often monitored with imaging and other tests that can be invasive, expensive, and limited in their ability to catch the disease early.
An experimental blood test could help detect early pancreatic cancer and precancerous changes, guiding decisions about further testing.
People at high risk of pancreatic cancer are often monitored with imaging and other tests that can be invasive, expensive, and limited in their ability to catch the disease early.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
An experimental blood test could help detect early pancreatic cancer and precancerous changes, guiding decisions about further testing. People at high risk of pancreatic cancer are often monitored with imaging and other tests that can be invasive, expensive, and limited in their ability to catch the disease early. An experimental blood test called PANXEON could [...]
An experimental blood test called PANXEON could [...]
Open the app view to save this story, compare related coverage, and continue from the same source.